Economic impact of early intervention in people at high risk of psychosis

Psychological Medicine

Volumn 39, Issue 10, 2009, Pages 1617-1626

  Valmaggia, L R ^a,b   McCrone, P ^a   Knapp, M ^a,c   Woolley, J B ^a   Broome, M R ^a   Tabraham, P ^a   Johns, L C ^a   Prescott, C ^a   Bramon, E ^a,d   Lappin, J ^a   Power, P ^d   McGuire, P K ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^d SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

At risk mental state; Cost effectiveness; Early detection; Early intervention; Psychosis

Indexed keywords

FLUOXETINE; QUETIAPINE;

ADULT; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE DURATION; DRUG DOSE INCREASE; EARLY INTERVENTION; ECONOMIC ASPECT; EMPLOYMENT; FEMALE; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; PATIENT REFERRAL; PSYCHOSIS; SENSITIVITY ANALYSIS;

COST-BENEFIT ANALYSIS; FEMALE; HUMANS; LONDON; MALE; PSYCHOTIC DISORDERS; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 70449623645     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291709005613     Document Type: Article

References (33)

1. Andlin-Sobocki P, Rössler W (2005). Cost of psychotic disorders in Europe. European Journal of Neurology 12, s74-s77.
2. Bentall RP, Morrison A (2002). More harm than good: the case against using anti-psychotic drugs to prevent severe mental illness. Journal of Mental Health 11, 351-356.
3. Broome MR, Woolley JB, Johns LC, Valmaggia LR, Tabraham P, Gafoor R, Bramon E, McGuire PK (2005). Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. European Psychiatry 20, 372-378.
4. Cannon TD, Cornblatt B, McGorry P (2007). The empirical status of the ultra high-risk (prodromal) research paradigm. Schizophrenia Bulletin 33, 661-664.
5. Cornblatt BA, Lencz T, Smith CW, Olsen R, Auther AM, Nakayama E, Lesser ML, Tai JT, Shah MR, Foley CA, Kane JM, Correll CU (2007). Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. Journal of Clinical Psychiatry 68, 546-557.
6. Correll CU, Penzner JB, Lencz T, Auther A, Smith CW, Malhotra AK, Kane JM, Cornblatt BA (2007). Early identification and high-risk strategies for bipolar disorder. Bipolar Disorders 9, 324-338.
7. Craig TKJ, Garety P, Power P, Rahaman N, Colbert S, Fornells-Ambrojo M, Dunn G (2004). The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. British Medical Journal 329, 1067-1072.
8. Curtis L, Netten A (2004). Unit Costs of Health and Social Care. University of Kent: Canterbury, Kent.
9. Department of Health (2001). The Mental Health Policy Implementation Guide. Department of Health: London.
10. Häfner H, Maurer K, Ruhrmann S, Bechdolf A, Klosterkötter J, Wagner M, Maier W, Bottlender R, Möller HJ, Gaebel W, Wölwer W (2004). Early detection and secondary prevention of psychosis: facts and visions. European Archives of Psychiatry and Clinical Neuroscience 254, 117-128.
11. Malla AK, Norman RM, Joober R (2005). First-episode psychosis, early intervention, and outcome: what have we learned? Canadian Journal of Psychiatry 50, 881-891.
12. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T (2005). Association between duration of untreated psychosis and outcome in cohorts of first episode psychosis. Archives of General Psychiatry 62, 975-983.
13. McCrone P, Jacobson B (2004). Indicators of mental health activity in London: adjusting for sociodemographic need (http://www.lho.org.uk/Download/ Public/8715/1/Mental-Health-Indicators-Final-Report-3.pdf) Accessed 18 March 2009.
14. McCrone P (2007). Health economic measures in schizophrenia research. British Journal of Psychiatry 191, s42-s45.
15. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A (2006). Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry 163, 790-799.
16. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry 59, 921-928.
17. McGuire PK (2002). Prodromal intervention: the need for evaluation. Journal of Mental Health 11, 469-470.
18. Mihalopoulos C, McGorry PD, Carter RC (1999). Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome? Acta Psychiatrica Scandinavica 100, 47-55.
19. Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, Woods SW (2002). Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive validity. American Journal of Psychiatry 159, 863-865.
20. Morgan C, Mallett R, Hutchinson G, Bagalote H, Morgan K, Fearon P, Dazzan P, Boydell J, McKenzie K, Harrison G, Murray R, Jones P, Craig T, Leff J; AESOP Study Group (2005). Pathways to care and ethnicity. 1: Sample characteristics and compulsory admission. Report from the AESOP study. British Journal of Psychiatry 186, 281-289.
21. Morrison AP, French P, Parker S, Roberts M, Stevens H, Bentall RP, Lewis SW (2007). Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophrenia Bulletin 33, 682-687.
22. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, Parker S, Bentall RP (2004). Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomized controlled trial. British Journal of Psychiatry 185, 291-297.
23. Netten A, Curtis L (2002). Unit Costs of Health and Social Care. PSSRU: Canterbury.
24. Office for National Statistics (2004). Annual survey of hours and earnings (ASHE)-2004 results (including supplementary information) (http://www.statistics. gov.uk/statbase/Product.asp?vlnk=13290). Accessed 18 March 2009.
25. Office for National Statistics (2009). NOMIS official labour market statistics (https://www.nomisweb.co.uk/). Accessed 18 March 2009.
26. Phillips LJ, Yung AR, McGorry PD (2000). Identification of young people at risk of psychosis: validation of personal assessment and crisis evaluation clinic intake criteria. Australian and New Zealand Journal of Psychiatry 34, S164-S169.
27. Phillips LJ, McGorry PD, Pan Yuen H, Ward J, Donovan K, Kelly D, Francey SM, Yung AR (2007). Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophrenia Research 96, 25-33.
28. Power P, McGuire P, Iacoponi E, Garety P, Morris E, Valmaggia LR, Grafton D, Craig T (2009). Lambeth Early Onset (LEO) and Outreach and Support in South London (OASIS) Service. Early Intervention in Psychiatry 1, 97-103.
29. Treeage Software Inc. (2002). Data 4.0. Treeage Software Inc.: Williamstown, MA.
30. Warner R (2005). Problems with early and very early intervention in psychosis. British Journal of Psychiatry 187, s104-s107.
31. Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, Patton GC, Jackson HJ (1998). Prediction of psychosis. A step towards indicated prevention in schizophrenia. British Journal of Psychiatry 172, 14-20.
32. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD (2003). Psychosis prediction: 12-month follow-up of a high-risk ('prodromal') group. Schizophrenia Research 60, 21-32.
33. Yung AR, Phillips LJ, Yuen HP, McGorry PD (2004). Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophrenia Research 67, 131-142.